![Daniel Abdun-Nabi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Abdun-Nabi
Directeur/Membre du Conseil chez
APTEVO THERAPEUTICS INC.
Fortune : - $ au 31/07/2026
Profil
Daniel J.
Abdun-Nabi is currently Director at Emergent Product Development UK Ltd. since 2008, Director at Biohealth Innovation, Inc. since 2013, Independent Director at Aptevo Therapeutics, Inc. since 2016, and Director at Emergent BioSolutions Canada, Inc. Formerly, Mr. Abdun-Nabi was Chief Executive Officer & Director at Emergent BioSolutions, Inc. from 2018 to 2019, Independent Director at REGENXBIO, Inc. from 2016 to 2022, Secretary, SVP-Legal Affairs & General Counsel at North American Vaccine, Inc. from 1999 to 2000, and General Counsel at both BioVeris Corp.
and IGEN International, Inc. from 1999 to 2004.
Education includes undergraduate studies at the University of Massachusetts, and graduate degrees from Georgetown University Law Center and the University of San Diego School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Daniel Abdun-Nabi
| Sociétés | Poste | Début |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/08/2016 |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Directeur/Membre du Conseil | 30/07/2013 |
Emergent BioSolutions Canada, Inc.
 Emergent BioSolutions Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes immune therapeutic drugs | Directeur/Membre du Conseil | - |
Emergent Product Development UK Ltd.
 Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, travelers diarrhea, hepatitis B and anthrax | Directeur/Membre du Conseil | 27/06/2008 |
Anciens postes connus de Daniel Abdun-Nabi
| Sociétés | Poste | Fin |
|---|---|---|
| REGENXBIO INC. | Directeur/Membre du Conseil | 03/06/2022 |
| EMERGENT BIOSOLUTIONS INC. | Directeur Général | 01/04/2019 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Conseiller Juridique Général | 01/05/2004 |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Conseiller Juridique Général | 01/05/2004 |
North American Vaccine, Inc.
 North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Conseiller Juridique Général | 01/01/2000 |
Formation de Daniel Abdun-Nabi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Health Technology |
BioVeris Corp.
BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Emergent Product Development UK Ltd.
Emergent Product Development UK Ltd. Pharmaceuticals: MajorHealth Technology Develops oral vaccines for typhoid, travelers diarrhea, hepatitis B and anthrax | Health Technology |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Finance |
Georgetown University Law Center
 Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Diego School of Law
 University of San Diego School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
Emergent BioSolutions Canada, Inc.
Emergent BioSolutions Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes immune therapeutic drugs | Health Technology |
